← Bioceres Crop Solutions Corp.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Share of profit or loss of joint ventures and associates | — | $2.1m | ($1.0m) | ($2.5m) | ($997k) | ($1.1m) | ($1.2m) | ($4.0m) | $1.1m | — | |
| Net Income | — | — | — | — | — | ($7.2m) |
$18.8m
+360.85%
|
$4.3m
-77.23%
|
($55.4m)
-1396.07%
|
($71.0m)
-28.03%
|
|
| Net Income From Continuing Operations | — | — | — | — | — | ($3.9m) | $20.2m | $7.3m | ($58.8m) | ($71.0m) | |
| Profit or Loss | — | — | ($16.4m) | $4.2m | ($3.8m) | ($3.9m) | $20.2m | $6.3m | ($58.8m) | — | |
| Depreciation of property, plant and equipment | — | $2.2m | $2.5m | $2.0m | $3.0m | $3.8m | $4.8m | $5.8m | $6.0m | $22.7m | |
| Amortization of intangible assets | — | $2.1m | $2.4m | $2.1m | $2.4m | $4.2m | $11.0m | $12.1m | $11.2m | — | |
| Depreciation of leased assets | — | — | — | $567k | $827k | $1.3m | $3.6m | $3.4m | $5.0m | $22.7m | |
| Amortization Cash Flow | — | — | — | — | — | $4.2m | $11.0m | $12.1m | $11.2m | — | |
| Amortization Of Intangibles | — | — | — | — | — | $4.2m | $11.0m | $12.1m | $11.2m | $11.8m | |
| Depreciation | — | — | — | — | — | $5.0m | $8.4m | $9.2m | $11.0m | $10.8m | |
| Depreciation Amortization Depletion | — | — | — | — | — | $9.2m | $19.4m | $21.3m | $22.2m | $22.7m | |
| Deferred Tax | — | — | — | — | — | $18.0m | ($1.1m) | $3.8m | $1.3m | $7.1m | |
| Adjustments For Share-Based Payments | — | — | — | $3.4m | $1.7m | $1.4m | $3.4m | $14.1m | $4.4m | — | |
| Share-based incentive and stock options | — | $30k | ($103k) | $3.4m | $1.7m | $1.4m | $3.4m | $14.1m | $4.4m | — | |
| Allowance for impairment of trade debtors | — | $1.3m | $687k | $1.5m | $561k | $1.6m | $1.3m | $753k | $7.1m | — | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | ($1.1m) | ($1.1m) | ($4.0m) | $1.1m | $531k | |
| Change In Working Capital | — | — | — | — | — | ($60.9m) | ($85.1m) | ($41.5m) | $19.3m | $60.0m | |
| Trade receivables | — | $17.3m | $41.5m | ($23.0m) | $2.0m | ($25.0m) | ($56.9m) | ($46.7m) | $25.5m | — | |
| Other receivables | — | $513k | $5.8m | ($4.8m) | ($8.3m) | ($7.3m) | ($11.5m) | ($5.0m) | ($916k) | — | |
| Change In Receivables | — | — | — | — | — | ($32.3m) | ($68.3m) | ($51.6m) | $24.6m | $38.2m | |
| Changes In Account Receivables | — | — | — | — | — | ($25.0m) | ($56.9m) | ($46.7m) | $25.5m | $38.2m | |
| Inventories and biological assets | — | — | ($8.6m) | ($5.3m) | ($34.5m) | ($55.3m) | ($11.1m) | $14.2m | $34.9m | — | |
| Change In Inventory | — | — | — | — | — | ($55.3m) | ($11.1m) | $14.2m | $34.9m | $26.9m | |
| Trade and other payables | — | ($35.3m) | ($33.7m) | $8.5m | ($5.8m) | $53.5m | ($4.5m) | $14.2m | ($32.0m) | — | |
| Deferred revenue and advances from customers | — | ($162k) | $66k | $865k | $2.4m | ($374k) | $13.3m | ($21.1m) | ($129k) | — | |
| Change In Other Current Liabilities | — | — | — | — | — | ($784) | $0 | — | — | — | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | — | $110k | $318k | $51k | $310k | $2.0m | $137k | $337k | $390k | — | |
| Gain on sale of equipment and intangible assets | — | $5k | $92k | $297k | $733k | ($1.9m) | ($75k) | ($125k) | ($7.8m) | — | |
| Purchase of property, plant and equipment | — | ($2.8m) | ($2.0m) | ($1.6m) | ($2.8m) | ($3.5m) | ($11.4m) | ($9.8m) | ($5.6m) | — | |
| Capital Expenditure Reported | — | — | — | — | — | ($5.1m) | ($10.8m) | ($11.9m) | ($8.6m) | ($9.7m) | |
| Net cash flows used by investing activities | — | ($8.2m) | ($3.3m) | ($22.2m) | ($8.3m) | $2.9m | ($25.7m) | ($28.7m) | ($6.1m) | — | |
| Cash flows from financing activities: | |||||||||||
| Proceeds From Borrowings Classified As Financing Activities | — | $27.7m | $88.7m | $135.3m | $143.5m | $140.4m | $79.8m | $135.8m | $266.4m | — | |
| Repayments Of Borrowings Classified As Financing Activities | — | — | $111.1m | $101.3m | $126.0m | $123.6m | $16.7m | $112.6m | $288.5m | — | |
| Repayment of borrowings and financed payments | — | ($37.6m) | ($111.1m) | ($101.3m) | ($126.0m) | ($110.6m) | ($16.7m) | ($112.6m) | ($288.5m) | — | |
| Issuance Of Debt | — | — | — | — | — | $140.4m | $79.8m | $135.8m | $266.4m | $204.9m | |
| Long Term Debt Issuance | — | — | — | — | — | $140.4m | $79.8m | $135.8m | $266.4m | $204.9m | |
| Long Term Debt Payments | — | — | — | — | — | ($111.7m) | ($20.6m) | ($117.5m) | ($294.0m) | ($271.0m) | |
| Net Issuance Payments Of Debt | — | — | — | — | — | $28.7m | $59.2m | $18.3m | ($27.6m) | ($66.1m) | |
| Net Long Term Debt Issuance | — | — | — | — | — | $28.8m | $59.2m | $18.3m | ($27.6m) | ($66.1m) | |
| Net Short Term Debt Issuance | — | — | — | — | — | ($33k) | $0 | $0 | — | $0 | |
| Repayment Of Debt | — | — | — | — | — | ($111.7m) | ($20.6m) | ($117.5m) | ($294.0m) | ($271.0m) | |
| Short Term Debt Payments | — | — | — | — | — | ($33k) | $0 | $0 | — | $0 | |
| Common Stock Payments | — | — | — | — | — | $0 | ($3.0m) | ($734k) | ($927k) | $0 | |
| Net Common Stock Issuance | — | — | — | — | — | $0 | ($3.0m) | ($734k) | ($927k) | $488k | |
| Repurchase Of Capital Stock | — | — | — | — | — | $0 | ($3.0m) | ($734k) | ($927k) | $0 | |
| Dividends paid | — | — | — | — | — | — | $452k | $175k | $72k | $0 | |
| Cash dividend distributed by subsidiary | — | — | — | — | — | — | ($452k) | ($175k) | ($72k) | — | |
| Cash Dividends Paid | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Net Other Financing Charges | — | — | — | — | — | ($905k) | ($5.2m) | ($2.9m) | ($3.3m) | ($2.5m) | |
| Net cash flows (used by)/ generated by financing activities | — | ($10.5m) |
($26.9m)
-157.67%
|
$33.5m
+224.44%
|
$7.4m
-78.06%
|
$14.8m
+101.46%
|
$33.0m
+122.31%
|
($10.1m)
-130.51%
|
($50.7m)
-404.24%
|
— | |
| Net (decrease)/ increase in cash and cash equivalents | — | ($291k) | ($512k) | $22.7m | ($7.2m) | $211k | $9.8m | $2.9m | ($6.9m) | — | |
| Cash and cash equivalents as of beginning of the year | $983k | $2.2m | $3.5m | $27.2m | $36.0m | $33.5m | $48.1m | $44.5m | $32.7m | — | |
| Beginning Cash Position | — | — | — | — | — | $36.0m | $33.5m | $48.1m | $44.5m | $25.0m | |
| Effect of exchange rate changes on cash and equivalents | — | $826k | $67k | $1.5m | $6.3m | $6.8m | $4.9m | ($6.6m) | ($4.9m) | ($9.2m) | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Additional Financial Items | |||||||||||
| Adjustments For Decrease Increase In Trade Account Receivable | — | — | $41.5m | ($23.0m) | $2.0m | ($25.0m) | ($56.9m) | ($46.7m) | $25.5m | — | |
| Adjustments For Finance Costs | — | — | $41.5m | $32.7m | $27.9m | $25.8m | $35.1m | $34.8m | $55.3m | — | |
| Adjustments For Income Tax Expense | — | ($10.9m) | $7.0m | $2.2m | $14.4m | $18.0m | ($1.1m) | $3.8m | $1.3m | — | |
| Goodwill | — | — | $29.8m | $25.5m | $28.8m | $36.1m | $112.2m | $112.3m | $112.2m | — | |
| Interest Paid Classified As Financing Activities | — | — | $20.2m | $21.5m | $12.9m | $13.0m | $18.0m | $24.7m | $18.9m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | $565k | $729k | $1.0m | $3.9m | $4.9m | $5.5m | — | |
| Payments To Acquire Or Redeem Entitys Shares | — | — | — | $31k | $3.5m | — | $3.0m | $734k | $927k | — | |
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | — | — | — | $5k | $9.3m | $12.3m | $1.3m | $888k | $19.3m | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | — | $615k | $723k | $1.6m | $7.2m | $389k | $450k | $1.1m | $351k | — | |
| (Loss)/ Profit for the year | — | ($14.3m) | ($16.4m) | $4.2m | ($3.8m) | ($3.9m) | $20.2m | $6.3m | ($58.8m) | — | |
| Financial results | — | $41.0m | $41.5m | $32.7m | $27.9m | $25.8m | $35.1m | $34.8m | $55.3m | — | |
| Transactional expenses | — | — | $4.5m | — | $2.0m | $972k | $4.2m | $1.1m | $4.0m | — | |
| Provisions for contingencies | — | $46k | ($247k) | $201k | $159k | $293k | $221k | $367k | $336k | — | |
| Allowance for obsolescence | — | $662k | $565k | $978k | $580k | $850k | $1.1m | $587k | $1.5m | — | |
| Initial recognition and changes in the fair value of biological assets | — | — | ($280k) | ($717k) | ($2.8m) | ($6.4m) | ($611k) | $46k | ($1.8m) | — | |
| Changes in the net realizable value of agricultural products after harvest | — | — | — | — | — | $43k | $4.4m | $2.4m | $1.5m | — | |
| Income and minimum presumed income taxes | — | ($127k) | $2.8m | $1.2m | $5.8m | $6.5m | ($16.2m) | $4.8m | ($7.0m) | — | |
| Employee benefits and social security | — | ($544k) | $932k | ($474k) | ($693k) | $3.0m | $1.3m | ($2.3m) | ($1.2m) | — | |
| Income taxes paid | — | ($71k) | ($1.7m) | — | ($1.8m) | ($7.1m) | ($4.1m) | ($853k) | $0 | — | |
| Interest collected | — | — | — | $1.0m | $3.0m | $5.6m | $5.4m | $2.7m | $121k | — | |
| Inflation effects on working capital adjustments | — | — | ($18.4m) | ($13.7m) | ($14.7m) | ($35.8m) | $377k | $321k | $140k | — | |
| Net cash received from business combination | — | — | — | — | $356k | — | $4.4m | $38k | — | — | |
| Proceeds from financial assets | — | — | — | $5k | $9.3m | $12.3m | $1.3m | $888k | $19.3m | — | |
| Investment in financial assets | — | — | — | ($17.8m) | ($4.3m) | ($2.1m) | ($9.0m) | ($7.2m) | ($11.2m) | — | |
| Capitalized development expenditures | — | ($2.3m) | ($683k) | ($1.3m) | ($3.9m) | ($5.1m) | ($10.8m) | ($11.9m) | ($8.6m) | — | |
| Purchase of intangible assets | — | ($615k) | ($723k) | ($1.6m) | ($7.2m) | ($389k) | ($450k) | ($1.1m) | ($351k) | — | |
| Interest payments | — | — | — | — | ($12.9m) | ($13.0m) | ($18.0m) | ($24.7m) | ($18.9m) | — | |
| Other financial payments | — | ($1.8m) | ($855k) | $2.3m | ($1.4m) | ($181k) | ($4.8m) | ($2.7m) | ($3.2m) | — | |
| Purchase of own shares | — | — | — | ($31k) | ($3.5m) | — | ($3.0m) | ($734k) | ($927k) | — | |
| Leased assets payments | — | — | — | ($434k) | ($729k) | ($1.0m) | ($3.9m) | ($4.9m) | ($5.5m) | — | |
| Inflation effects on cash and cash equivalents | — | — | $1.7m | ($552k) | ($5.6m) | ($9.6m) | ($102k) | ($32k) | $3k | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | $14.8m | $33.0m | ($10.1m) | ($50.7m) | ($81.4m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | $2.9m | ($25.7m) | ($28.7m) | ($6.1m) | ($5.7m) | |
| Change In Account Payable | — | — | — | — | — | $53.5m | ($4.5m) | — | — | $22.6m | |
| Change In Cash Supplemental As Reported | — | — | — | — | — | $211k | $9.8m | $2.9m | ($6.9m) | — | |
| Change In Other Working Capital | — | — | — | — | — | ($26.7m) | ($1.2m) | ($18.3m) | ($8.2m) | ($10.3m) | |
| Change In Payable | — | — | — | — | — | $53.5m | ($4.5m) | $14.2m | ($32.0m) | $22.6m | |
| Change In Tax Payable | — | — | — | — | — | $6.5m | ($16.2m) | — | — | ($3.6m) | |
| Changes In Cash | — | — | — | — | — | $211k | $9.8m | $2.9m | ($6.9m) | ($8.3m) | |
| End Cash Position | — | — | — | — | — | $33.5m | $48.1m | $44.5m | $32.7m | $16.7m | |
| Financing Cash Flow | — | — | — | — | — | $14.8m |
$33.0m
+122.31%
|
($10.1m)
-130.51%
|
($50.7m)
-404.24%
|
($81.4m)
-60.49%
|
|
| Free Cash Flow | — | — | — | — | — | ($26.5m) | ($20.0m) | $18.9m | $35.3m | $72.2m | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | ($1.9m) | ($75k) | ($125k) | ($7.8m) | ($7.6m) | |
| Interest Received CFO | — | — | — | — | — | $5.6m | $5.4m | $2.7m | $121k | $667k | |
| Investing Cash Flow | — | — | — | — | — | $2.9m | ($25.7m) | ($28.7m) | ($6.1m) | ($5.7m) | |
| Net Business Purchase And Sale | — | — | — | — | — | $0 | $4.4m | $38k | $0 | $0 | |
| Net Intangibles Purchase And Sale | — | — | — | — | — | ($389k) | ($450k) | ($1.1m) | ($351k) | ($99k) | |
| Net Investment Purchase And Sale | — | — | — | — | — | $10.3m | ($7.7m) | ($6.3m) | $8.1m | $3.7m | |
| Net PPE Purchase And Sale | — | — | — | — | — | ($1.4m) | ($11.2m) | ($9.5m) | ($5.3m) | ($3.2m) | |
| Operating Gains Losses | — | — | — | — | — | ($3.1m) | ($1.1m) | ($4.2m) | ($6.6m) | ($7.1m) | |
| Other Cash Adjustment Outside Changein Cash | — | — | — | — | — | ($9.6m) | ($102k) | ($32k) | $3k | — | |
| Other Non Cash Items | — | — | — | — | — | $20.4m | $43.0m | $37.3m | $59.1m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | $0 | $0 | — | — | $0 | |
| Provisionand Write Offof Assets | — | — | — | — | — | $2.7m | $2.6m | $1.7m | $9.0m | $8.7m | |
| Purchase Of Business | — | — | — | — | — | $0 | $0 | — | — | $0 | |
| Purchase Of Intangibles | — | — | — | — | — | ($389k) | ($450k) | ($1.1m) | ($351k) | ($99k) | |
| Purchase Of Investment | — | — | — | — | — | ($2.1m) | ($9.0m) | ($7.2m) | ($11.2m) | ($6.3m) | |
| Purchase Of PPE | — | — | $2.0m | $1.6m | $2.8m | ($3.5m) | ($11.4m) | ($9.8m) | ($5.6m) | ($9.7m) | |
| Sale Of Business | — | — | — | — | — | $0 | $4.4m | $38k | $0 | $0 | |
| Sale Of Investment | — | — | — | — | — | $12.3m | $1.3m | $888k | $19.3m | $10.0m | |
| Sale Of PPE | — | — | — | — | — | $2.0m | $137k | $337k | $390k | $261k | |
| Stock Based Compensation | — | — | — | — | — | $1.4m | $3.4m | $14.1m | $4.4m | $2.2m |